Prospective data on hip fracture from 3686 patients at a United Kingdom teaching hospital were analysed to investigate the risk factors, financial costs and outcomes associated with deep or superficial wound infections after hip fracture surgery.
There are an estimated 86 000 hip fractures in the United Kingdom every year, with an annual cost of £1.7 billion to the National Health Service and social care services. 3 Some 95% of hip fractures occur in individuals aged over 60 years, 4 and, with an increasingly aged population, the number of cases is expected to rise. 5 The majority of the costs of hip fractures are due to hospital stay and theatre time. A previous study in our institution of 100 patients aged over 60 undergoing routine treatment of femoral neck fracture calculated the mean cost of hospital care to be £12 163. 6 Pollard et al 7 calculated the cost of treating a patient with a proximal femoral fracture who developed a deep wound infection to be £24 410 and £7210 for a non-infected control group. Despite the high cost of hip fractures and the associated rates of SSI, little has been published on the added financial cost of infection following hip fracture surgery. The aim of this study was to evaluate the risk factors, incidence, bacteriology, treatment and mortality after surgery for fracture of the hip which is complicated by SSI, and to estimate the cost of treating this complication.
Patients and Methods
At our United Kingdom teaching hospital, data on all hip fracture admissions are collected prospectively by independent audit assistants. The data collection is based on the Standardised Audit of Hip Fractures in Europe. 8 Audit data are strictly confidential and are managed in accordance with Caldicott principles. 9 The institutional ethics committee are aware of this work. Post-operative complications are identified and recorded. Any patient admitted with an SSI following discharge from hospital is also identified. Our hospital is the only facility providing emergency care for our catchment population of approximately 750 000. Therefore, it is likely that most late infections will present back to our unit and be collected by the audit.
In this study, a retrospective analysis was performed of the notes of all hip fracture patients identified as having an SSI admitted between 8 May 1999 and 8 May 2004. All hospital episodes from the date of hip fracture until the study date (October 2004) were analysed. Patients with peri-prosthetic fractures were excluded from the analysis; this was the only exclusion criterion for the study. All patients reviewed had SSI of their primary proTrauma cedure, rather than having complications of a secondary procedure. In order to produce a comparable data set, a control sample of 80 non-infected patients was identified from the population of 3686 hip fracture cases using a random number generator.
We identified 3563 consecutive patients who had been treated surgically for their hip fracture. There were no simultaneous bilateral procedures. Surgery was performed in laminar flow theatres. All patients received prophylactic intravenous antibiotics at induction, and two further doses of intravenous antibiotics post-operatively. In most cases cefradine (1.0 g) was used for prophylaxis unless the patient had a penicillin allergy, in which case 1.2 g vancomycin was given. The administration of prophylactic antibiotics in the unit has been previously audited and compliance was very high (> 99%). Gentamicin-impregnated cement was used for all cemented implants.
The diagnosis and type of SSI were verified from the hospital notes and microbiology records. The SSI was considered to be deep if, at surgery, it was deep to the deep fascia, if the wound was left open or drained, if the implant was removed, or if there was radiological evidence of infection. Any patient who commenced antibiotic treatment for wound problems and did not meet the criteria for deep infection was deemed to have a superficial wound infection, irrespective of any microbiology results.
The duration of surgery and type of implant used were obtained from the notes. The cost of one hour of operating time was calculated by combining estimated costs for staff in the operating room and recovery, use of equipment, sterile services and disposable surgical and anaesthetic items. The estimated cost for one hour of operating was £1347. The number of days spent on either the ward, a higher dependency unit or intensive care unit was recorded and valued at £320.52, £670 and £1575, respectively. Length of stay was calculated as time on the critical care and acute orthopaedic wards, but not the in-hospital rehabilitation wards. The number of days for which a vacuumassisted dressing was used and for which various antibiotics were prescribed was recorded. Other drug costs were included into the hospital mean bed-stay cost. The number of investigations performed on each patient was obtained from the hospital computer systems. Bacteriology. Superficial wound swabs were processed using a variety of selective media to identify aerobic and anaerobic pathogens. Samples of pus and tissue were plated on to non-selective agar for aerobic and anaerobic incubation, and also suspended in an enrichment broth culture, both of which were incubated for five days. Statistical analysis. The infection and control groups were compared using Pearson's chi-squared test and independent samples t-tests. Risk analysis was conducted using binary logistic regression methods for categorical data. Data were coded and stored in Microsoft Excel, Windows 2000 (Microsoft Corp, Redmond, Washington) and analysed using SPSS version 14.0 (SPSS Inc., Chicago, Illinois).
Results
Patient demographics. Between 8 May 1999 and 8 May 2004, 3686 patients were admitted to our institution with hip fractures; 123 patients were treated non-operatively, the remaining 3563 were treated surgically. Of the surgically-treated patients, 80 (2.3%) developed an SSI; 41 (1.2%) of these infections were deep and 39 (1.1%) were superficial.
Demographically, there were no statistically significant differences between the patients who developed an SSI and those who did not (Table I ). In terms of age and gender the groups were broadly comparable. In the infected group there was a slightly higher percentage of patients with intracapsular fractures and a slightly lower percentage of patients with extracapsular fractures compared with the non-infected group. However, this result was not statistically significant. The earliest diagnois of deep infection occurred at two days after surgery whereas the latest presentation was at 84 days. The diagnosis of infection was made during the primary hospital admission in 24 of 80 patients (30%); 56 patients were re-admitted with an SSI. Type of surgery. There was a wide variation in infection rates depending on the type of implant used (Table II) . There were 28 fractures treated with a dynamic condylar screw plate, (Synthes Ltd, Welwyn Garden City, United Kingdom) and two became infected, three times the overall mean infection rate. The infection rate following fractures treated by Austin Moore uncemented hemiarthroplasty (Stryker UK Ltd, Newbury, United Kingdom) and intramedullary hip screw was also higher than the mean infection rate. In contrast, no infections were seen in patients who underwent Exeter hemiarthroplasty (Stryker UK Ltd). There were three infections in patients with a Thompson hemiarthroplasty (Stryker UK Ltd).
Bacteriology. Nearly half of the infections (39; 49%) were caused by MRSA (Table III) . Methicillin-sensitive Staph. aureus (MSSA) was isolated in 24% (19 cases). In 11% of cases (nine) no bacteriology specimens were obtained, mainly because these were episodes of wound erythema for which antibiotics were prescribed but no pus was present at the wound surface to allow collection. These cases have been classified as superficial wound infection to avoid underestimation of the infection rate. A single deep infection was identified for which no bacteriology specimens had been obtained. Staphylococci, both methicillin-resistant and methicillinsensitive, were identified as the causative organisms in a greater proportion of deep wound infections (34 of 41, 82.9%) than in superficial wound infections (24 of 39, 61.5%). The bacteriology in some cases grew more than one infecting organism. This was due to either differerent organisms on repeat specimens or mixed organisms on a single specimen. The effect of infection type. Regardless of the infective organism, hospital costs, mean length of stay and predis- Staphylococcus epidermidis
* some infections had a mixed growth of bacteria, resulting in the total numbers of bacteria identified exceeding the number of infections (Table IV) . Infection with MRSA caused slight increases in hospital costs, length of stay and predischarge mortality but the results were not statistically significant (p = 0.964, p = 0.260 and p = 0.262, respectively) ( Table V) . Mortality. The 30-day mortality rate in cases with SSI was less than that in the hip fracture population without SSI. Interestingly, 390 patients of the 3606 (10.8%) who did not develop SSI following hip fracture treatment, 123 of whom were treated non-operatively, died within 30 days and four of the 80 patients who developed SSI died within 30 days (5.0%). This bias is perhaps because the SSI group selects those who survive long enough past their injury and surgery for SSI to become apparent. The non-infected group includes some patients whose prognosis was too poor to be treated surgically and therefore could not develop SSI.
As seen in Figures 1 and 2 , after the initial 30-day period the mortality rate for SSI increased such that at one year post-operatively approximately 50% of patients (40) whose hip fracture had been complicated by SSI had died, compared with 30% (108 patients) of those who did not have SSI. As no correlation was found between comorbidities and SSI, this is likely to be due to the effects of the infections and their treatments. Discharge outcome. Table VI shows the destination of patients leaving the acute hospital setting for the first time following their hip fracture. Those leaving the orthopaedic unit for 'hospital' were, in the main, discharged to a community hospital facility, but did include a few patients who were transferred to another acute department within the hospital for unrelated problems. As can be seen in Table VI , 24 patients (30%) who developed SSI following their hip fracture died before leaving hospital compared with 871 (24.2%) who did not develop an infection (p = 0.006). This may be a reflection of the increased length of stay of infected patients. Risk factors. Univariate analysis was used to assess the importance of various risk factors on the incidence of SSI in Graph showing cumulative mortality up to one year.
these patients (Table VII) . Patient age and gender were not found to have a significant effect on the likelihood of developing SSI following hip fracture. When analysed individually, pre-operative cardiovascular disease, stroke, respiratory disease, renal disease, diabetes, rheumatoid arthritis, Parkinson's disease, malignancy and Paget's disease were not significant risk factors for the development of SSI in hip fracture patients. Smoking, taking more than four medications, or warfarin also did not significantly increase the hazard-ratio for SSI. The mini-mental test score 10 on admission did not affect the risk of developing SSI. The only risk factor that had a near-significant effect on the risk of developing SSI following hip fracture surgery was taking oral steroids on admission. This was found to almost double the hazard ratio for SSI (odds ratio 2.2, 95% confidence interval (CI) 0.9 to 5.6, p = 0.09). The type of fracture or length of wait for surgery had no influence on the risk of developing SSI (Table VIII) . The grade of surgeon operating did not influence SSI rate, but operations lasting more than 240 minutes carried a significantly higher SSI risk (p = 0.02). Whereas most implants did not notably influence the risk of infection, two implants stood out. The Austin-Moore hemiarthroplasty had an odds ratio of 2.4 compared with our baseline operation of AO screw fixation with 95% CI of 0.9 to 6.8 and p = 0.09, and of even greater significance was the dynamic condylar screw plate with odds ratio of 5.6 and 95% CI 0.9 to 32.1, p = 0.05. Costs. The presence of SSI following hip fracture treatment significantly increased all costs (p < 0.001), with the mean total costs for treating an infected case reaching £25 940.44 (£4387 to £93 976), compared with £8978.56 (£3450 to £72 564) for treating an uninfected case (Table IX) . For deep wound infections the mean increased to £34 903 (£9408 to £93 976). This increase is due mainly to the increased length of stay. Patients without SSI stayed for a mean of 22 days following a hip fracture. Those with a superficial wound infection stayed for a mean of 50 days, whereas those with deep infections stayed for a mean of 100 days. Generally, SSI doubled the operative costs, tripled the costs of investigations, and quadrupled the ward costs compared with hip fracture patients who did not suffer this complication.
Discussion
We found a deep infection rate of 1.2%. This is low compared with other studies, which quote infection rates between 1.3% 1 and 3.6%. 2 These low rates may reflect the use of laminar flow theatres for all hip fracture surgery and excellent compliance with appropriate antibiotic prophylaxis.
We calculated the mean cost of treating a patient with SSI after hip fracture surgery as £25 940.44 (£4387 to £93 976). When the cost of treating a patient with a deep wound infection is compared with the mean cost of treating uninfected hip fractures in the same centre (£8978.56), it represents approximately a threefold increase in cost. Pollard et al 7 reported costs of £24 210 per deep infection. This value does not take into account added costs postdischarge. After a prolonged hospital stay and the added insult of infection, there may be longer outpatient followup, increased physiotherapy, rehabilitation and community care, in the form of either home help or nursing home care.
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The length of stay costs were 82% of the total; operative costs added 13%, and the remainder were the costs of investigations and antibiotics. These figures are similar to those from previous data on the surgical treatment of hip fracture, 6 although the length of stay is greatly increased in our institution. The mean length of stay of patients with SSI was 76 days, with a mean length of stay of 50 days for superficial wound infections and 100 days for deep wound infections. In comparison, the mean length of stay for those without an infection was 22 days. Other studies have found that the mean length of stay for those without an infection ranged from 23 to 28 days, 6, 8, 12 and for those with an infection the mean was 80 days.
Mortality at 30 days for patients with SSI after hip fracture surgery was 10.8% (390 patients). In comparison, mortality without infection was 5% (four patients). Roche et al 13 reported a mortality rate of 9.6% at 30 days and of 33% at one year. Vidal et al 14 reported a 21.5% one-year mortality rate, and Bottle and Aylin 15 14.3% in hospital mortality. In our study, 30-day mortality in the noninfected patients was more than twice that of the infected cohort (10.8%, compared with 5%). Some of these patients may have been infected but did not survive long enough for this to become clinically apparent and some were treated non-operatively as they were very frail. In contrast, one year after hip fracture the mortality rate among patients who had developed SSI was 50%, compared with 30% in those who had not. This increased mortality in association with infection may be due to a combination of patient factors that predisposed to infection, as well as the effects of the infection and complications from management, such as 16 Mackay et al 2 and Lee et al 17 report Staph. aureus rates of 40% and 56%, respectively, but with no differentiation for methicillin resistance; lower values than our combined figure of 74%.
Length of stay, pre-discharge mortality and cost all increased with MRSA deep wound infections compared with non-MRSA infections. The mean length of stay for patients with deep MRSA wound infections was 109 days, compared with 90 days for non-MRSA infection. Predischarge mortality among patients with deep MRSA wound infection increased to 48% (ten patients) compared with 35% (seven patients) with non-MRSA. The mean costs of treating patients with deep MRSA wound infections was £38 464, £7300 more than for non-MRSA infections. The additional costs and mortality associated with deep MRSA infections may reflect more costly antibiotics used, and the more significant side effects than those in the treatment of other infection.
These data suggest that SSI after hip fracture surgery is associated with substantial increases in mortality, morbidity and costs. Furthermore, MRSA infection increases predischarge mortality, length of stay and cost compared with non-MRSA infection.
Despite having such a large cohort in this study we were unable to identify easily remediable risks that may be addressed to reduce SSI rates. Patients with a hip fracture taking steroids on admission were over twice as likely to develop SSI, but this did not reach statistical significance. Diabetes and renal disease may also mildly increase the risk of developing SSI, but this was also not statistically significant. It may be that this is a type II error, and that our sample size was simply not large enough. Many of the frequently cited patient risk-factors for SSI, such as coexisting malignancy, appeared in this analysis to be protective. 17 It should be borne in mind, however, that these risk factors are also risk factors for mortality, and it may be that some patients with these risk factors died before SSI became clinically evident.
The higher the grade of surgeon performing hip fracture surgery, the lower the risk of SSI was found to be, although this result was not statistically significant. More complex surgical procedures with larger exposures and more tissue dissection, such as the dynamic condylar screw carried an increased risk of developing infection compared with less invasive techniques such as AO screw fixation, but these results were not statistically significant. Only for extremely lengthy surgery could a significant increase in SSI risk be demonstrated.
Surgical site infection after hip fracture surgery has huge implications both financially, and on mortality and morbidity.
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